Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study. (Q51800530)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 June 2006

Language	Label	Description	Also known as
English	Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study.	scientific article published on 9 June 2006

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

circulatory system

1 reference

based on heuristic

inferred from title

Tomonori Sugiura

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Akihiko Takahashi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Hiroyuki Takase

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Takayuki Toriyama

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Yutaka Kurita

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Ryuzo Ueda

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Yasuaki Dohi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

0 references

publication date

9 June 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

2507-2512

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Chronic kidney disease: the global challenge

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Vascular inflammation and the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Candesartan Reduces Oxidative Stress and Inflammation in Patients with Essential Hypertension

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Cardiovascular Mortality in End-Stage Renal Disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Angiotensin receptor blockers and myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Effects of excess calcium load on the cardiovascular system measured with electron beam tomography in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL293

21 January 2018

Identifiers

10.1093/NDT/GFL293

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766543%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51800530&oldid=1239453311"